Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
07 5월 2024 - 7:00PM
Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic
therapeutics company focused on pioneering new approaches for the
treatment of obesity and type 2 diabetes (T2D), today announced it
will report financial results for the first quarter 2024 and
provide business updates after market close on Monday, May 13,
2024. The Company’s management will host a conference call on the
same day beginning at 4:30 p.m. ET.
A live webcast of the conference call can be accessed in the
“Events” section of Fractyl’s website at www.ir.fractyl.com. The
webcast will be archived and available for replay following the
live event.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on
pioneering new approaches to the treatment of metabolic diseases,
including obesity and T2D. Despite advances in treatment over the
last 50 years, obesity and T2D continue to be rapidly growing
drivers of morbidity and mortality in the 21st century. Fractyl
Health’s goal is to transform metabolic disease treatment from
chronic symptomatic management to durable disease-modifying
therapies that target the organ-level root causes of disease.
Fractyl Health is based in Burlington, MA. For more information,
visit www.fractyl.com or https://twitter.com/FractylHealth.
Contacts
Corporate Contact Lisa Davidson, Chief Financial
Officer ir@fractyl.com, 781.902.8800
Media Contact Beth Brett, Corporate
Communications bbrett@fractyl.com, 720.656.6544
Investor Contact Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
Fractyl Health (NASDAQ:GUTS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Fractyl Health (NASDAQ:GUTS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024